First clinical proof-of-concept that FMT can overcome resistance to ICIs Editorial
| Authors: | Elkrief, A.; Routy, B. |
| Title: | First clinical proof-of-concept that FMT can overcome resistance to ICIs |
| Keywords: | advanced cancer; nonhuman; note; melanoma; evidence based practice; monoclonal antibody; antibiotic resistance; engraftment; colonoscopy; allogeneic hematopoietic stem cell transplantation; predictive value; translational research; programmed death 1 receptor; clinical outcome; proof of concept; bifidobacterium; eubacterium; microbiome; immune checkpoint inhibitor; species diversity; preclinical study; metagenomics; human; priority journal; fecal microbiota transplantation; pembrolizumab; population abundance; commensalism; akkermansia muciniphila; ruminococcus |
| Journal Title: | Nature Reviews Clinical Oncology |
| Volume: | 18 |
| Issue: | 6 |
| ISSN: | 1759-4774 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2021-06-01 |
| Start Page: | 325 |
| End Page: | 326 |
| Language: | English |
| DOI: | 10.1038/s41571-021-00502-3 |
| PUBMED: | 33742164 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Note -- Export Date: 1 July 2021 -- Source: Scopus |
